© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 90702 refers to the administration of diphtheria and tetanus toxoids adsorbed (DT) specifically for individuals who are younger than 7 years of age. This vaccine is administered via intramuscular injection and is designed to provide long-lasting immunity against the diseases caused by the toxins produced by the bacteria responsible for diphtheria and tetanus. Toxoids are inactivated forms of the toxins that stimulate the immune system to produce antibodies, which are crucial for neutralizing the harmful effects of these toxins. The process of creating a toxoid involves culturing the bacteria in a controlled liquid medium, followed by purification and inactivation of the toxin produced. It is important to note that since toxoids are not live vaccines, the immunity they confer can diminish over time, necessitating booster doses to maintain adequate protection. The code 90702 specifically reports the use of the diphtheria and tetanus toxoids (DT) product administered to eligible patients, emphasizing its role in immunization for young children.
© Copyright 2025 Coding Ahead. All rights reserved.
The administration of diphtheria and tetanus toxoids adsorbed (DT) is indicated for the immunization of individuals younger than 7 years. This vaccine is crucial for protecting against the diseases caused by the toxins of diphtheria and tetanus, which can lead to severe health complications if contracted. The primary indications for this procedure include:
The procedure for administering diphtheria and tetanus toxoids adsorbed (DT) involves several key steps to ensure safety and efficacy. Each step is critical to the successful immunization of the patient.
Post-procedure care for the administration of diphtheria and tetanus toxoids adsorbed (DT) includes monitoring the patient for any immediate side effects, which may include mild fever, soreness at the injection site, or irritability. It is essential to inform the patient or guardian about these potential reactions and to advise them on when to seek medical attention. Additionally, the importance of completing the full vaccination series, including any necessary booster doses, should be emphasized to ensure long-term immunity against diphtheria and tetanus. Documentation of the vaccine administration, including the date, lot number, and site of injection, is also crucial for maintaining accurate medical records.
Short Descr | DT VACCINE UNDER 7 YRS IM | Medium Descr | DT VACCINE YOUNGER THAN 7 YRS FOR IM USE | Long Descr | Diphtheria and tetanus toxoids adsorbed (DT) when administered to individuals younger than 7 years, for intramuscular use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | 1 | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GA | Waiver of liability statement issued as required by payer policy, individual case | GZ | Item or service expected to be denied as not reasonable and necessary | JZ | Zero drug amount discarded/not administered to any patient | SL | State supplied vaccine |
Date
|
Action
|
Notes
|
---|---|---|
2016-01-01 | Changed | First appearance of change in codebook. |
2015-07-01 | Changed | Description Changed |
2013-01-15 | Changed | Corrected short and medium descriptions per AMA corrections document dated 2013-01-15. |
2013-01-01 | Changed | Description Changed |
2011-01-01 | Changed | Short description changed. |
2008-01-01 | Changed | Code description changed. |
2007-01-01 | Changed | Code description changed. |
2005-01-01 | Changed | Code description changed. |
2001-01-01 | Changed | Code description changed. |
Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.